Grants
Every research grant awarded by the Ovarian Cancer Research Alliance, by program, year and institution.
2026 · Collaborative Research Development Grant
Targeting EPOR Positive Tumor-Associated Macrophages in High Grade Serous Ovarian Cancer
Stanford University
2026 · Mentored Investigator Grant
Enhancing Anti-tumor Response Through Regulation of Cancer-associated Fibroblasts in Ovarian Cancer
University of California, San Francisco
2026 · Mentored Investigator Grant
Investigating the Role of VGF in Ovarian Cancer Quiescence and Treatment Resistance
Magee-Womens Research Institute
2026 · Mentored Investigator Grant
Targeting IL1α/and Infiltrated Neutrophils to Kill Chemo-/and ICI-resistant Ovarian Tumor Metastases
The Wistar Institute
2026 · Mentored Investigator Grant
Targeting Cancer Stem Cell Vulnerability in Ovarian Cancer
University of California, Irvine
2026 · Mentored Investigator Grant
Mechanisms of PARPi Resistance in BRCA1/2-associated High Grade Serous Ovarian Carcinoma
Memorial Sloan Kettering Cancer Center
2026 · Mentored Investigator Grant
Deciphering Spatiotemporal T Cell Clonal Dynamics to Optimize Immunotherapy in Ovarian Cancer
Icahn School of Medicine at Mount Sinai
2026 · Mentored Investigator Grant
Decoding the Early Immune and Genomic Alterations Driving HGSC Initiation
Memorial Sloan Kettering Cancer Center
2026 · Mentored Investigator Grant
A Novel Function for BRCA1 E3 Ligase Activity in Regulating PARP Inhibitor Sensitivity in HGSOC
Dana-Farber Cancer Institute
2026 · AI Accelerator Grant
AI to Predict Exceptional and Poor Survival From Real World Biomarkers for Clinical Application
University of Michigan
2026 · Health Equity Research Grant
Assessing Inequities in Ovarian Cancer Access and Quality Using Big Data
The University of North Carolina at Chapel Hill
2026 · Health Equity Research Grant
Role of neighborhood socio-structural factors on the tumor epigenome and racial disparities
Emory University
2026 · Early Career Investigator Grant
Machine learning models to predict refractory responses in ovarian cancer
Icahn School of Medicine at Mount Sinai
2026 · Early Career Investigator Grant
Leveraging Immunogenic Subtypes of High-Grade Serous Ovarian Cancer for Improved Therapy Selection
Wake Forest University Health Sciences
2026 · Early Career Investigator Grant
Removing fibrotic barriers to improve immunotherapy responses in ovarian cancer
Sanford Burnham Prebys Medical Discovery Institute
2026 · Early Career Investigator Grant
Learning spatial determinants of treatment response in ovarian cancer
Massachusetts General Hospital
2026 · Collaborative Research Development Grant
Targeting ovarian cancer control of the tumor microenvironment to enhance anti-tumor immunity
Icahn School of Medicine at Mount Sinai
2026 · Collaborative Research Development Grant
First-in-human Folate Receptor alpha-targeted BiTE-secreting T cells ovarian cancer clinical trial
Roswell Park Cancer Institute
2026 · Collaborative Research Development Grant – Microsoft's AI for Good Lab
Ovarian Cancer Risk Reduction through AI-Driven Prediction of Variant Pathogenicity
University of New Mexico
2026 · Early Career Investigator Grant
Investigating the Role of Chromosomal Instability in Ovarian Cancer Initiation
Memorial Sloan Kettering Cancer Center
2025 · Rivkin Center/CARE Fund
A Vaccine to Prevent Ovarian Cancer Metastatic Spread
University of Washington
2025 · Rivkin Pilot Grant
Engineering natural killer cells to target ovarian cancer tumors via metabolite-sensing receptors
The Board of Trustees of the Leland Stanford Junior University
2025 · Rivkin Pilot Grant
In vivo engineering of B7-H3.CAR-T cell therapy for ovarian cancer
The University of North Carolina at Chapel Hill
2025 · Mentored Investigator Grant
CD74 Mediates the Interaction between Ovarian Cancer Cells and the High Fat Metastatic Niche
The Methodist Hospital Research Institute